All Pharma News
price-trendAsk Us
Amphivena Presents Translational Data Highlighting the Cytokine Profile

Amphivena Presents Translational Data Highlighting the Cytokine Profile
BUSINESSWIRE
13 Apr 2021
Share Share
Amphivena Presents Translational Data Highlighting the Cytokine Profile

Amphivena Presents Translational Data Highlighting the Cytokine Profile
BUSIESSWIRE
13 Apr 2021
Share Share
Amphivena Announces First Patient Dosed in the Phase 1 Dose of AMV564

Amphivena Announces First Patient Dosed in the Phase 1 Dose of AMV564
BIOSPACE
16 Dec 2020
Share Share
Amphivena Presents Clinical Update and Translational Data of AMV564

Amphivena Presents Clinical Update and Translational Data of AMV564
PRNEWSWIRE
09 Nov 2020
Share Share
Amphivena Presents Translational Data for its Lead Clinical Candidate, AMV564

Amphivena Presents Translational Data for its Lead Clinical Candidate, AMV564
PRNEWSWIRE
23 Jun 2020
Share Share
Amphivena Presents Data from First-in-Human Study of AMV564 in Solid Tumor

Amphivena Presents Data from First-in-Human Study of AMV564 in Solid Tumor
PRNEWSWIRE
29 May 2020
Share Share
Amphivena Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Amphivena Therapeutics to Present at the Jefferies Virtual Healthcare Conference
PRNEWSWIRE
29 May 2020
Share Share
Amphista Therapeutics Raises $7.5m Series A Round

Amphista Therapeutics Raises $7.5m Series A Round
Jason Mast PR NEWSWIRE
07 Apr 2020
Share Share
Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted

Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted
PR NEWSWIRE
06 Apr 2020
Share Share